These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1909414)

  • 21. Subcellular distribution of the transmissible agent in Creutzfeldt-Jakob disease mouse brain.
    Tamai Y; Kojima H; Ohtani Y; Uchida K; Taguchi F; Kawaguchi T; Miura S; Tateishi J
    Microbiol Immunol; 1989; 33(1):35-42. PubMed ID: 2659945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane filtration and the Creutzfeldt-Jakob agent.
    Taylor DM
    Lancet; 1985 Dec 21-28; 2(8469-70):1430-1. PubMed ID: 2867425
    [No Abstract]   [Full Text] [Related]  

  • 23. Endogenous viral complexes with long RNA cosediment with the agent of Creutzfeldt-Jakob disease.
    Akowitz A; Sklaviadis T; Manuelidis L
    Nucleic Acids Res; 1994 Mar; 22(6):1101-7. PubMed ID: 8152913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Successful transmission of Creutzfeldt-Jakob disease from human to mouse verified by prion protein accumulation in mouse brains.
    Muramoto T; Kitamoto T; Tateishi J; Goto I
    Brain Res; 1992 Dec; 599(2):309-16. PubMed ID: 1291035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinetics of infectivity are dissociated from PrP accumulation in salivary glands of Creutzfeldt-Jakob disease agent-inoculated mice.
    Sakaguchi S; Katamine S; Yamanouchi K; Kishikawa M; Moriuchi R; Yasukawa N; Doi T; Miyamoto T
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2117-23. PubMed ID: 8409936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic control of scrapie and Creutzfeldt-Jakob disease in mice.
    Kingsbury DT; Kasper KC; Stites DP; Watson JD; Hogan RN; Prusiner SB
    J Immunol; 1983 Jul; 131(1):491-6. PubMed ID: 6408182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of Creutzfeldt-Jakob disease prion propagation by the A224V mutation.
    Watts JC; Giles K; Serban A; Patel S; Oehler A; Bhardwaj S; Guan S; Greicius MD; Miller BL; DeArmond SJ; Geschwind MD; Prusiner SB
    Ann Neurol; 2015 Oct; 78(4):540-53. PubMed ID: 26094969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth and spread of causative agent of Creutzfeldt-Jakob disease in intraperitoneally infected mice.
    Chino F; Ohkawa T
    Jpn J Med Sci Biol; 1990 Dec; 43(6):197-208. PubMed ID: 2101136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Creutzfeldt Jakob disease. Recommended precautions for patient management and diagnostic procedures (author's transl)].
    Brown P; Cathala F; Gajdusek DC
    Rev Neurol (Paris); 1978 Apr; 134(4):277-86. PubMed ID: 364589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spiroplasma-like inclusions in Creutzfeldt-Jakob disease.
    Bastian FO
    Arch Pathol Lab Med; 1979 Dec; 103(13):665-9. PubMed ID: 389196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scrapie and Creutzfeldt-Jakob disease prions.
    Prusiner SB; Barry RA; McKinley MP; Bellinger CG; Meyer RK; DeArmond SJ; Kingsbury DT
    Microbiol Sci; 1985; 2(2):33-9. PubMed ID: 3940147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of IL-1β Signaling Normalizes NMDA-Dependent Neurotransmission and Reduces Seizure Susceptibility in a Mouse Model of Creutzfeldt-Jakob Disease.
    Bertani I; Iori V; Trusel M; Maroso M; Foray C; Mantovani S; Tonini R; Vezzani A; Chiesa R
    J Neurosci; 2017 Oct; 37(43):10278-10289. PubMed ID: 28924012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immortality of cell cultures derived from brains of mice and hamsters infected with Creutzfeldt-Jakob disease agent.
    Manuelidis EE; Fritch WW; Kim JH; Manuelidis L
    Proc Natl Acad Sci U S A; 1987 Feb; 84(3):871-5. PubMed ID: 3543937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
    Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
    Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions.
    Taguchi Y; Mohri S; Ironside JW; Muramoto T; Kitamoto T
    Am J Pathol; 2003 Dec; 163(6):2585-93. PubMed ID: 14633630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions.
    Chapuis J; Moudjou M; Reine F; Herzog L; Jaumain E; Chapuis C; Quadrio I; Boulliat J; Perret-Liaudet A; Dron M; Laude H; Rezaei H; Béringue V
    Acta Neuropathol Commun; 2016 Feb; 4():10. PubMed ID: 26847207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent developments in scrapie and Creutzfeldt-Jakob disease.
    Manuelidis L; Manuelidis EE
    Prog Med Virol; 1986; 33():78-98. PubMed ID: 3092282
    [No Abstract]   [Full Text] [Related]  

  • 38. Cell fusion induced by scrapie and Creutzfeldt-Jakob virus-infected brain preparations.
    Kidson C; Moreau MC; Asher DM; Brown PW; Coon HG; Gajdusek DC; Gibbs CJ
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2969-71. PubMed ID: 208080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Safety measures for handling laboratory specimen and patients with Creutzfeldt-Jakob disease].
    Van Everbroeck B; Pals P; Cras P
    Ned Tijdschr Geneeskd; 1999 Jul; 143(29):1511-4. PubMed ID: 10443273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive transmission of Creutzfeldt-Jakob disease verified by murine kuru plaques.
    Kitamoto T; Tateishi J; Sawa H; Doh-Ura K
    Lab Invest; 1989 Apr; 60(4):507-12. PubMed ID: 2468821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.